Alexandra Maclean - Net Worth and Insider Trading
Alexandra Maclean Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alexandra Maclean owns 1 companies in total, including Avenue Therapeutics Inc (ATXI) .
Click here to see the complete history of Alexandra Maclean’s form 4 insider trades.
Insider Ownership Summary of Alexandra Maclean
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATXI | Avenue Therapeutics Inc | 2022-08-01 | Chief Executive Officer |
Alexandra Maclean Trading Performance
Alexandra Maclean Ownership Network
Alexandra Maclean Owned Company Details
What does Avenue Therapeutics Inc do?
Who are the key executives at Avenue Therapeutics Inc?
Alexandra Maclean is the Chief Executive Officer of Avenue Therapeutics Inc. Other key executives at Avenue Therapeutics Inc include 10 percent owner Fortress Biotech, Inc. , 10 percent owner Invagen Pharmaceuticals, Inc. , and Int. PEO & Int. PFO & and COO David Jin .
Avenue Therapeutics Inc (ATXI) Insider Trades Summary
Over the past 18 months, Alexandra Maclean made no insider transaction in Avenue Therapeutics Inc (ATXI). Other recent insider transactions involving Avenue Therapeutics Inc (ATXI) include a net purchase of 439 shares made by Jay D Kranzler , a net sale of 617,000 shares made by , and a net purchase of 418,410 shares made by Fortress Biotech, Inc. .
In summary, during the past 3 months, insiders sold 84 shares of Avenue Therapeutics Inc (ATXI) in total and bought 500 shares, with a net purchase of 416 shares. During the past 18 months, 8,311 shares of Avenue Therapeutics Inc (ATXI) were sold and 10,728 shares were bought by its insiders, resulting in a net purchase of 2,417 shares.
Avenue Therapeutics Inc (ATXI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avenue Therapeutics Inc Insider Transactions
Alexandra Maclean Mailing Address
Above is the net worth, insider trading, and ownership report for Alexandra Maclean. You might contact Alexandra Maclean via mailing address: C/o Avenue Therapeutics, Inc., 2 Gansevoort Street, 9th Floor, New York Nc 10014.